TY  - GEN
N2  - ​This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted c.
AB  - ​This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted c.
T1  - BRAF targets in melanomabiological mechanisms, resistance, and drug discovery /
AU  - Sullivan, Ryan J.,
VL  - volume 82
CN  - RC280.M37
N1  - Includes index.
ID  - 724550
KW  - Melanoma
SN  - 9781493921430
SN  - 1493921436
TI  - BRAF targets in melanomabiological mechanisms, resistance, and drug discovery /
LK  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-1-4939-2143-0
UR  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-1-4939-2143-0
ER  -